Eiger BioPharmaceuticals, Inc. Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Eiger BioPharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2014 to 2023.
  • Eiger BioPharmaceuticals, Inc. Return On Equity for the quarter ending December 31, 2023 was -870 %, a 650% decline year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Return On Equity for 2023 was -870 %, a 650% decline from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Return On Equity for 2022 was -116 %, a 240% decline from 2021.
  • Eiger BioPharmaceuticals, Inc. annual Return On Equity for 2021 was -34.2 %, a 62% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -870 -754 -650% Jan 1, 2023 Dec 31, 2023
2022 -116 -81.8 -240% Jan 1, 2022 Dec 31, 2022
2021 -34.2 +55.7 +62% Jan 1, 2021 Dec 31, 2021
2020 -89.8 +15.4 +14.7% Jan 1, 2020 Dec 31, 2020
2019 -105 +22.3 +17.5% Jan 1, 2019 Dec 31, 2019
2018 -127 +68.5 +35% Jan 1, 2018 Dec 31, 2018
2017 -196 -97.2 -98.3% Jan 1, 2017 Dec 31, 2017
2016 -98.9 -58.6 -145% Jan 1, 2016 Dec 31, 2016
2015 -40.3 -37.1 -1134% Jan 1, 2015 Dec 31, 2015
2014 -3.27 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.